Clinical Trials on Covid-19 Infections in Argentina

Total 627 results

Administracion Nacional de Laboratorios e Institutos...

Recruiting

Safety and Effectiveness of an Immunobiological Drug in CoViD-19 (INPB001)

Covid19 | COVID-19 Pneumonia | COVID-19 Respiratory Infection

Argentina
Laboratorio Elea Phoenix S.A.
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Completed

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

COVID-19 Virus Infection

Argentina
Laboratorios Roemmers S.A.I.C.F.

Unknown

Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

COVID-19

Argentina
Hospital General de Niños Pedro de Elizalde

Completed

Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital

Telehealth

Argentina
Sanatorio Finochietto

Completed

Tocilizumab in Covid-19 Penumonia in Buenos Aires City

COVID-19 Pneumonia | Tocilizumab

Argentina
Tiva Group

Unknown

Use of the Nasal Cannula During COVID-19

COVID 19

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

COVID-19 Vaccines

Argentina
Laboratorio Pablo Cassará S.R.L.
National Council of Scientific and Technical Research, Argentina; Universidad...

Completed

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

COVID-19 Vaccine

Argentina
Fundacion Infant

Completed

Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection

Covid19 | Pregnancy Related | Neonatal Infection

Argentina
Hospital de Clinicas José de San Martín
SILVATEAM

Terminated

Tannin Specific Natural Extract for COVID-19 Infection (TanCOVID)

COVID-19 | Coronavirus Infection | SARS-CoV 2

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19

Tocilizumab | Severe COVID 19 Pneumonia

Argentina
Ministry of Public Health, Argentina
Russian Direct Investment Fund

Recruiting

Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina (ECEHeVac)

Covid19 | COVID-19 VACCINE

Argentina
RUTI Immunotherapeutics S.L.

Completed

Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

Covid-19

Argentina
Fernando Saldarini
Hospital de Infecciosas Francisco Javier Muniz; Universidad Nacional de la... and other collaborators

Completed

COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A

Long COVID

Argentina
Laboratorio Elea Phoenix S.A.
Carlos R. Rojo, MD; Facultad de Medicina, Universidad de Buenos Aires, UBA

Completed

Telmisartan for Treatment of COVID-19 Patients

COVID-19 Drug Treatment

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Recruiting

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

COVID-19 Vaccines

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Active, not recruiting

Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.

COVID-19 Vaccines

Argentina
Laboratorio Elea Phoenix S.A.
Universidad Nacional de Salta; Centro de Investigación Veterinaria Tandil CIVETAN and other collaborators

Completed

Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19

COVID-19 Drug Treatment

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES

COVID-19

Argentina
Fundación Huésped
Ministerio de Salud de Ciudad Autónoma de Buenos Aires; Laboratorios Roemmers...

Recruiting

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts (PENTZ)

Covid19 | SARS-CoV-2 Infection | Households Contacts

Argentina
Arturo Jauretche National University
University of Buenos Aires; Hospital El Cruce; Universidad Nacional de La Plata; National University of Cuyo

Recruiting

Clinical and Biological Characterization of Post COVID-19 Syndrome

Long COVID

Argentina
Ministry of Public Health, Argentina

Completed

Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC) (IVERNEX-TUC)

Covid19

Argentina
Sanatorio Anchorena San Martin

Completed

Healthcare-associated Infections in Severe COVID-19 During 2020 (COVIACS)

COVID-19 | Respiration, Artificial | Health Care Associated Infection

Argentina
Hospital Nacional Profesor Alejandro Posadas

Completed

HYPONATREMIA IN COVID-19 PATIENTS

Covid19 | Corona Virus Infection | Hyponatremia

Argentina
Instituto de Cardiología de Corrientes

Completed

Ivermectin to Prevent Hospitalizations in COVID-19 (IVERCORCOVID19)

Covid19

Argentina
Argentinian Intensive Care Society

Completed

Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina (SATICOVID19)

Covid-19 | Respiratory Failure | Mechanical Ventilation

Argentina
Asociacion Latinoamericana de Torax

Completed

COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina) (COVIDPas)

COVID-19

Argentina
Eurnekian Public Hospital

Completed

USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 (IVERCAR)

Covid19

Argentina
Estudios Clínicos Latino América
Population Health Research Institute

Completed

The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. (COLCOVID)

COVID-19

Argentina
Hospital Italiano de Buenos Aires
National Agency for Scientific and Technological Promotion, Argentina

Unknown

Liver Transplantation and Coronavirus Disease 2019 (COVID-19)

Covid19 | Liver Transplant

Argentina
Centro de Educación Medica e Investigaciones Clínicas...

Completed

Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia

Covid19 Pneumonia

Argentina
Hospital Italiano de Buenos Aires
Ministerio de Salud de Ciudad Autónoma de Buenos Aires

Completed

Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina (COVID-19)

COVID-19

Argentina
Estudios Clínicos Latino América
Amarin Pharma Inc.

Completed

PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial (PREPARE-IT)

COVID19

Argentina
Hospital de Infecciosas Francisco Javier Muniz

Completed

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Covid19 | SARS-CoV Infection | SARS-Associated Coronavirus

Argentina
Ariel Dogliotti
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

Unknown

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease (CARR-COV-02)

Covid19

Argentina
Australian National University
Helwan University; Coney Island Hospital, Brooklyn, NY; Galeno Desenvolvimento... and other collaborators

Active, not recruiting

Inhaled Heparin for Hospitalised COVID-19 Patients (INHALE-HEP)

Covid19

Argentina, Egypt
Ministry of Public Health, Argentina

Completed

Ivermectin Reproposing for Mild Stage COVID-19 Outpatients (IVER-Leve)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Maria de los Angeles Peral de Bruno

Completed

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Austral University, Argentina

Unknown

Liver Injury in Patients With COVID-19

Liver Injury

Argentina
Hospital Italiano de Buenos Aires

Completed

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

Healthcare Workers | Vaccine | Coronavirus 2019

Argentina
Eurnekian Public Hospital

Completed

Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 (IDEA)

Severe Acute Respiratory Syndrome | Ventilation Pneumonitis

Argentina
Sanatorio Anchorena San Martin

Completed

Characteristics of Weaning From Mechanical Ventilation in COVID-19 (CovWean)

COVID-19 | Respiration, Artificial

Argentina
Centro de Educación Medica e Investigaciones Clínicas...
National Council of Scientific and Technical Research, Argentina; Laboratorio... and other collaborators

Completed

ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine (ARVAC-F2/3)

COVID-19 Vaccine

Argentina
Hospital Italiano de Buenos Aires

Completed

Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease (COVID-19)

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients (IRCIP)

Covid19

Argentina
Hoffmann-La Roche
Atea Pharmaceuticals, Inc.

Terminated

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study (MEADOWSPRING)

COVID-19 | Long COVID

Denmark, Switzerland, Turkey, Belgium, Mexico, Brazil, Argentina, Germany, Romania, Ukraine
Hospital Italiano de Buenos Aires
University of Buenos Aires; Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

Renal Dialysis | Coronavirus Disease 2019 Vaccines

Argentina
Golden Biotechnology Corporation

Completed

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

Covid-19

United States, Argentina, Peru
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.

Withdrawn

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

COVID-19 Acute Respiratory Distress Syndrome

Argentina, Peru
Fundación Huésped
CanSino Biologics Inc.; Canadian Center for Vaccinology; Hospital Fernandez

Recruiting

Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older. (COVID-19)

Covid19

Argentina

Clinical Trials on Covid-19 Infections in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations